Published July 13, 2011
Northwestern Innovations and New Ventures Office
Assistant Professor C. Shad Thaxton describes how his company, Aurasense, has made the leap from a university research lab to the marketplace.
AuraSense Therapeutics Expands Leadership Team
AuraSense Therapeutics Appoints Biotechnology Veteran David S. Snyder as Chief Financial Officer
Bill Gates among new backers of Skokie startup
AuraSense Therapeutics Completes $13.6 Million Series C Equity Investment
New System for Treating Cancer Seen as Hopeful